Prosecution Insights
Last updated: October 27, 2026

Symrise AG

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

43 pending office actions • 16 art units • 37 examiners • 0 of 43 (0%) have an AI response strategy ready • 25 patents granted in the last 365 days

Analysis

Symrise AG has 41 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 36 distinct examiners and 17 distinct art units, showing a substantial prosecution program distributed across numerous examiner and examination-group contexts. The difference between action volume and examiner count indicates that some examiner relationships include more than one current matter, while the art-unit spread requires broader portfolio coordination.

KAMM, JUDITH MARIE is the busiest examiner, with 3 pending matters. That assignment is the largest reported examiner concentration, but it remains one part of a docket handled across many examiners. Counsel should combine centralized tracking and recurring-issue analysis with application-specific review of scientific claims, evidence, and amendment consequences.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

43
Total Pending OAs
29
Non-Final OAs
14
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

13
Overdue
0
Due this week
4
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (13)Due ≤ 30 days (4)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

21
Hard (49%)
22
Medium (51%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (5%)
§103 only15 (35%)
Double-patenting + other7 (16%)
Multi-statute (no §101)19 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

42
Life Sciences
98% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

430 h
Manual time on pending OAs
86 h
Time saved (low, 20%)
150 h
Time saved (mid, 35%)
3.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KAMM, JUDITH MARIE 3 42.9% +57.1%
MRUK, BRIAN P 2 74.2% +28.1%
TIEN, LUCY MINYU 2 59.1% +36.8%
BERRIOS, JENNIFER A 2 37.1% +49.3%
KERSHAW, KELLY P 2 17.7% +16.0%
BOYER, CHARLES I 1 70.4% +19.7%
LOVE, TREVOR M 1 43.1% +26.8%
ALAWADI, SARAH 1 37.7% +38.3%
AHVAZI, BIJAN 1 63.1% +47.6%
SASAN, ARADHANA 1 64.6% +26.0%

Hard Cases (22)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18009288 Compositions Comprising Natural Polymers and One or More (Bio)-Alkanediols LIU, TRACY 103d overdue
17909693 COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE L STEINKE, SEAN JAMES 66d overdue
17774777 Colored particles ABBAS, ABDULRAHMAN MUSTAFA 44d overdue
15888433 MEDICAMENT BABSON, NICOLE PLOURDE 35d overdue
18009312 Compositions Comprising Antimicrobials and (Bio)-Alkanediols for Skin Protection LEE, ANDREW P 32d overdue
18301090 Compositions Comprising (Bio)-Alkanediols BERRIOS, JENNIFER A 11d overdue
18283565 A LIQUID DETERGENT COMPOSITION OGDEN JR, NECHOLUS 12d
18443435 ANTIMICROBIAL MIXTURE YU, HONG 13d

Interview Candidates (16)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18301090 Compositions Comprising (Bio)-Alkanediols BERRIOS, JENNIFER A 11d overdue
18301004 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols TIEN, LUCY MINYU 10d overdue
18009284 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols TIEN, LUCY MINYU 10d overdue
17435777 MIXTURE COMPRISING D-ALLULOSE AND TASTE MODIFYING COMPOUNDS KERSHAW, KELLY P 27d
18019793 Process for the Preparation of Microcapsules MRUK, BRIAN P 54d
18842428 Fixative Molecules BOYER, CHARLES I —
18837180 Composition Comprising Microcapsules for Solid Consumer Products LOVE, TREVOR M —
18784266 ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE ALAWADI, SARAH —

Top Art Units

Art UnitApps
1612 6
1611 5
1619 5
1761 5
1791 5
1763 2
1614 2
1692 2
1613 2
1793 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18842428 Fixative Molecules BOYER, CHARLES I — §103 Final Rejection — Pending Aug 29, 2024
18837180 Composition Comprising Microcapsules for Solid Consumer Products LOVE, TREVOR M 1611 §103 Non-Final OA — Pending Aug 08, 2024
18784266 ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE ALAWADI, SARAH 1619 §102§103§112Other Non-Final OA — Pending Jul 25, 2024
18833384 New Coolants, and Preparations Containing Same KAMM, JUDITH MARIE 1611 §102§103§112DP Non-Final OA — Pending Jul 25, 2024
18711193 FRAGRANCES AND FRAGRANCE MIXTURES AHVAZI, BIJAN 1763 §103§112 Non-Final OA — Pending May 17, 2024
18687161 ANTIMICROBIAL COMBINATIONS SASAN, ARADHANA 1615 §102§112DP Non-Final OA — Pending Feb 27, 2024
18443435 ANTIMICROBIAL MIXTURE YU, HONG 1614 §102§103Other Non-Final OA 13d Pending Feb 16, 2024
18684024 COMPOSITIONS LAZARO, DOMINIC 1611 §103§112 Final Rejection 70d Pending Feb 15, 2024
18577687 Biobased Core-Shell Microcapsules LING, DORIS 1761 §102§103 Non-Final OA — Pending Jan 08, 2024
18577496 Fragrance or Aroma Compositions Accepted or Preferred by Pets WHITELEY, JESSICA 1763 §102§112 Non-Final OA — Pending Jan 08, 2024
18283565 A LIQUID DETERGENT COMPOSITION OGDEN JR, NECHOLUS 1761 §102§103§112 Final Rejection 12d Pending Sep 22, 2023
18548993 TOILET RIM BLOCKS WITH SCENT CHANGE MRUK, BRIAN P 1761 §103 Non-Final OA — Pending Sep 05, 2023
18547173 BIOTECHNOLOGICAL PRODUCTION OF MEAT-LIKE FLAVOURINGS LI, CHANGQING 1791 §103§112 Non-Final OA — Pending Aug 21, 2023
18277133 2,6,6-TRIMETHYL-NORPINAN-2-OL AS AN ODORIFEROUS SUBSTANCE WALKER, AJA ARYANNA 1761 §103§112 Non-Final OA — Pending Aug 14, 2023
18276518 MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION WISTNER, SARAH CLINKSCALES 1616 §102§103§112DP Final Rejection 26d overdue Pending Aug 09, 2023
18267563 CATALYST SYSTEM WITHERSPOON, SIKARL A 1692 §103 Non-Final OA — Pending Jun 15, 2023
18256458 PRODUCTION OF PROTEIN-CARBOHYDRATE CONJUGATES AS EMULSIFIERS DIVIESTI, KARLA ISOBEL 1792 §103§112 Final Rejection — Pending Jun 08, 2023
18265840 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES ROBERTS, LEZAH 1612 §103 Non-Final OA — Pending Jun 07, 2023
18301004 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols TIEN, LUCY MINYU 1612 §103DP Non-Final OA 10d overdue Pending Apr 14, 2023
18301051 Compositions Comprising (Bio)-Alkanediols with Antimicrobials for Product Protection KAMM, JUDITH MARIE 1611 §103§112Other Non-Final OA — Pending Apr 14, 2023
18301090 Compositions Comprising (Bio)-Alkanediols BERRIOS, JENNIFER A 1613 §101§102§103§112Other Final Rejection 11d overdue Pending Apr 14, 2023
18247026 Aroma Composition Having a Grill-Type Flavour Profile SHELLHAMMER, JAMES PAUL 1793 §103 Non-Final OA 23d Pending Mar 28, 2023
18025333 STARCH-BASED CLOUDING EMULSION AND SPRAY-DRIED STARCH-BASED CLOUDING AGENT FOR BEVERAGES KOHLER, STEPHANIE A 1791 §103 Non-Final OA 4d overdue Pending Mar 08, 2023
18019793 Process for the Preparation of Microcapsules MRUK, BRIAN P 1761 §103DP Final Rejection 54d Pending Feb 03, 2023
18019783 Polyurea/Polyurethane Microcapsules WASHVILLE, JEFFREY D 1766 §103 Non-Final OA 16d overdue Pending Feb 03, 2023
18019786 Method for Producing Microcapsules WERTZ, ASHLEE ELIZABETH 1612 §103DP Final Rejection 58d overdue Pending Feb 03, 2023
18015160 COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY BROWE, DAVID 1617 §102§112 Non-Final OA — Pending Jan 09, 2023
18009289 Compositions Comprising UV-Filters and One or More (Bio)-Alkanediols HOLLOMAN, NANNETTE 1612 §103 Non-Final OA — Pending Dec 08, 2022
18009312 Compositions Comprising Antimicrobials and (Bio)-Alkanediols for Skin Protection LEE, ANDREW P 1691 §102§103 Final Rejection 32d overdue Pending Dec 08, 2022
18009316 Process for the Efficient Preparation of (Bio)-Alkanediols BAHTA, MEDHANIT W 1692 §103 Non-Final OA 66d overdue Pending Dec 08, 2022
18009288 Compositions Comprising Natural Polymers and One or More (Bio)-Alkanediols LIU, TRACY 1614 §101§103 Non-Final OA 103d overdue Pending Dec 08, 2022
18009284 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols TIEN, LUCY MINYU 1612 §103DP Final Rejection 10d overdue Pending Dec 08, 2022
18009295 Compositions Comprising (Bio)-Alkanediols with Antimicrobials for Product Protection KAMM, JUDITH MARIE 1611 §103Other Final Rejection — Pending Dec 08, 2022
17997835 FLAVOUR COMPOSITIONS FOR IMPROVING TASTE IMPRESSIONS MERCHLINSKY, JOSEPH CULLEN 1791 §103 Final Rejection 56d Pending Nov 03, 2022
17909693 COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE L STEINKE, SEAN JAMES 1619 §102§103 Final Rejection 66d overdue Pending Sep 06, 2022
17909342 COMPOSITION COMPRISING AN AVENANTHRAMIDE OR AN ANALOGUE THEREOF WITH IMPROVED STABILITY OLSEN, KAELEIGH ELIZABETH 1619 §102§103§112Other Non-Final OA — Pending Sep 02, 2022
17774777 Colored particles ABBAS, ABDULRAHMAN MUSTAFA 1612 §103§112 Non-Final OA 44d overdue Pending May 05, 2022
17768677 ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN GOTFREDSON, GAREN 1619 §103§112 Non-Final OA — Pending Apr 13, 2022
17615894 A COOLING PREPARATION BERRIOS, JENNIFER A 1613 §103 Final Rejection — Pending Dec 02, 2021
17435777 MIXTURE COMPRISING D-ALLULOSE AND TASTE MODIFYING COMPOUNDS KERSHAW, KELLY P 1791 §103§112 Non-Final OA 27d Pending Sep 02, 2021
17435751 MIXTURES COMPRISING RARE SUGARS AND TASTE MODIFYING COMPOUNDS KERSHAW, KELLY P 1791 §103Other Non-Final OA — Pending Sep 02, 2021
15780346 SUBSTANCE MIXTURES MORNHINWEG, JEFFREY P 1793 §103 Non-Final OA — Pending Sep 27, 2018
15888433 MEDICAMENT BABSON, NICOLE PLOURDE 1619 §103§112 Non-Final OA 35d overdue Pending Feb 05, 2018

Managing Symrise AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Symrise AG have?

Symrise AG has 43 pending office actions as of October 2026, spread across 16 art units and 37 examiners.

Which USPTO examiner handles the most Symrise AG applications?

Judith Marie Kamm has the most, with 3 of Symrise AG's pending office actions.

What technology area are Symrise AG's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month